NanoViricides, Inc. Has Filed its Quarterly Report – Subsequent Raise Has Fortified Fiscal Position

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...
BMJ Global Health

Assessing the role of Australia’s Pharmaceutical Benefits Scheme as a tool for addressing inequality in access to medications and allocation of public funds for pre…

Introduction Medication use during pregnancy is common, and socioeconomic disparities in access may contribute to maternal ...